Today: 16 April 2026
Subscribe
Browse Category

NASDAQ:MWH 12 February 2026

Solv Energy stock jumps 23% after Nasdaq IPO debut — what to watch next for MWH

Solv Energy stock jumps 23% after Nasdaq IPO debut — what to watch next for MWH

SOLV Energy’s Class A shares closed at $30.67, up 22.7% from the $25 IPO price, after debuting on Nasdaq under “MWH.” The company raised $512.5 million by selling 20.5 million shares, valuing it at about $5 billion. The IPO is expected to close Feb. 12, with Jefferies and J.P. Morgan as lead underwriters. The offering was more than 10 times oversubscribed, IFR reported.
12 February 2026
···

Stock Market Today

  • Indian Stock Markets Rise on April 16 as US-Iran Conflict Hopes Boost Sentiment
    April 16, 2026, 12:26 AM EDT. The Indian stock market saw gains on April 16, with the Nifty50 opening above 24,350 and BSE Sensex climbing over 400 points amid easing oil prices and hopes for an early end to the US-Iran conflict. Nifty50 was up 0.52% at 24,357.25, and Sensex rose 0.59% to 78,573.80. Analysts note the rebound comes after a 12% correction since the war's start 47 days ago. Small and mid-cap stocks outperformed large caps, reflecting renewed investor confidence. Global markets also showed strength, with the S&P 500 and Nasdaq hitting record highs, driven by strong earnings and optimism about a ceasefire. Foreign investors bought Rs 666 crore in equities, supporting the uptrend. Market watchers remain cautious of disruptions in the Strait of Hormuz despite improving risk sentiments.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 16.04.2026

16 April 2026
LIVEMarkets rolling coverageStarted: April 16, 2026, 12:00 AM EDTUpdated: April 16, 2026, 12:26 AM EDT Indian Stock Markets Rise on April 16 as US-Iran Conflict Hopes Boost Sentiment April 16, 2026, 12:26 AM EDT. The Indian stock market saw gains on April 16, with the Nifty50 opening above 24,350 and BSE Sensex climbing over 400 points amid easing oil prices and hopes for an early end to the US-Iran conflict. Nifty50 was up 0.52% at 24,357.25, and Sensex rose 0.59% to 78,573.80. Analysts note the rebound comes after a 12% correction since the war's start 47 days ago. Small and
Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Go toTop